Australian Sarcona Study Group: Development and outlook

Cancer Forum

Volumn 33, Issue 1, 2009, Pages 25-28

  Thomas, David ^a,b   Whyte, Sally ^b   Choong, Peter ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b Australia Sarcoma Study Group   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; SUNITINIB;

ARTICLE; AUSTRALIA; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL TRIAL; DRUG RESPONSE; EWING SARCOMA; HEALTH CARE COST; HUMAN; INTERDISCIPLINARY RESEARCH; OSTEOSARCOMA; QUALITY OF LIFE; SARCOMA; SOFT TISSUE SARCOMA; THERAPY EFFECT; UNSPECIFIED SIDE EFFECT;

EID: 63649138421     PISSN: 0311306X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Australian Institute of Health and Welfare; Australasian Association of Cancer Registries. Cancer in Australia 1998: Incidence and mortality data for 1998. Cancer series no. 17. AIHW cat. no. CAN 12. 2001 [cited 2008 Dec 12]. Available from: www.aihw.gov.au/publications/can/ca98/.
2. Giles G, Thursfield V, editors. Canstat: Cancer in Victoria 2001. Melbourne: The Cancer Council Victoria Epidemiology Centre; 2003.
3. Begg S, Vos T, Barker B, Stevenson C, Stanley L, Lopez AD. The burden of disease and injury in Australia 2003. Canberra: Australian Institute of Health and Welfare; 2007 [cited 2007 Nov 14]. Available from: http://www.aihw.gov.au/publications/hwe/bodaiia03/bodaiia03-c00.pdf
4. Australian Institute of Health and Welfare. Health and Welfare Expenditure Series Number 22: Health system expenditures on cancer and other neoplasms in Australia, 2000-01. Canberra: Australian Institute of Health and Welfare; 2005 [cited 2007 Nov 14]. Available from: http://www.aihw.gov.au/publications/hwe/hsecna00-01/hsecna00-01.pdf.
5. cdc.gov/nchs/lhomepage on the Internet]. Atlanta, Georgia: Centers for Disease Control and Prevention. [updated 2008 Dec 11; cited 2008 Dec 12]. Available from: http://www.cdc.gov/nchs/.
6. Bleyer A, Montello M, Budd T, Saxman S. National survival trends of young adults with sarcoma: lack of progress is associated with lack of clinical trial participation. Cancer. 2005;103:1891-7.
7. Australian Institute of Health and Welfare. Health and Welfare Expenditure Series Number 22: Health system expenditures on cancer and other neoplasms in Australia, 2000-01. Canberra: Australian Institute of Health and Welfare; 2005 [cited 2007 Nov 14]. Available from: http://www.aihw.gov.au/publications/hwe/hsecna00-01/hsecna00-01.pdf.
8. Mitchell AE, Scarcella DL, Rigutto GIL, Thursfield VJ, Giles GG, Sexton M, et al. Cancer in adolescents and young adults: treatment and outcome in Victoria. Med J Aust. 2004;180:59-62.
9. National Cancer Institute. Soft Tissue Sarcoma. Bethesda (United States): National Cancer Institute; no date [cited 2008 June 12]. Available from: www.cancergov/cancertopics/types/soft-tissue-sarcoma/.
10. gicancer.org.au [homepage on the Internet]. Sydney: Australasian Gastro-Intestinal Trials Group; 2008 [cited 2008 Dec 12]. Available from: http://www.gicancer.org.au/trials/index.html
11. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 2005 Jan 7;307(5706):58-62.
12. Brizel DIM, Rosner GIL, Harrelson J, Prosnitz LR, Dewhirst MW. Pretreatment oxygenation profiles of human soft tissue sarcomas. Int J Radiat Oncol Biol Phys. 1994;30:635-42.
13. Evans SM, Hahn SM, Magarelli DP, Zhang PJ, Jenkins WT, Fraker DL, et al. Hypoxia in human intraperitoneal and extremity sarcomas. Int J Radiat Oncol Biol Phys. 2001;49:587-96.